While most ccRCC tumors have elevated expression of angiopoietin-like4 (ANGPTL4), in our study we identified a significant subset of patients whose cancers show no increase in ANGPTL4 expression. This evidence concerns the gene ANGPTL4 and nonpapillary renal cell carcinoma.